Clover Health Investments (CLOV) reported $1.9B in revenue for fiscal 2025, +40.3% year on year. That ranks #1359 by revenue among 2853 SEC filers and #124 in Healthcare. It posted a net loss of −$85.5M for the same year. Revenue has grown 26.8% a year on average since 2019 ($462M then). The fiscal 2025 balance sheet shows $541M in total assets, $78.3M in cash and $0 in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenues | $1.9B | +40.3% | FY20252025-12-31 |
| Gross profitGrossProfit | $257M | +266.3% | FY20232023-12-31 |
| Operating incomeOperatingIncomeLoss | −$85.5M | −$39.8M | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$85.5M | −$42.5M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | −$66.9M | −$102M | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $2.0M | +31.3% | FY20252025-12-31 |
| Total assetsAssets | $541M | −6.8% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $309M | −9.5% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $78.3M | −59.8% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $0 | −100.0% | FY20222022-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $749M | $27.3M | Open → |
| Q2 20262026-06-30 | $743M | $28.0M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 132 of 161 companies compared | −4.4% | |
| Operating marginRank 138 of 160 companies compared | −4.4% | |
| Cash as share of revenueRank 130 of 160 companies compared | 4.1% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Clover Health Investments, Corp.
- Ticker
- CLOV
- Exchange
- Nasdaq
- SIC classification
- Hospital & Medical Service Plans (6324)
- Fiscal year end
- 12-31
- CIK
- 0001801170
Filings
- 10-QAug 7, 2026Open filing →
- 10-QMay 8, 2026Open filing →
- 10-KFeb 27, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| TeleflexTFX | $2.0B | −$906M |
| National VisionEYE | $2.0B | $29.6M |
| ModernaMRNA | $1.9B | −$2.8B |
| Clover Health InvestmentsCLOV | $1.9B | −$85.5M |
| Pediatrix MedicalMD | $1.9B | $165M |
| Msa SafetyMSA | $1.9B | $279M |
| Integer HoldingsITGR | $1.9B | $103M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Clover Health Investments — Key figures |url=https://companiesranked.com/en/company/clover-health-investments |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Clover Health Investments — Key figures. CompaniesRanked. https://companiesranked.com/en/company/clover-health-investmentsBibTeX
@misc{companiesranked-en-company-clover-health-investments-2026,
author = {{CompaniesRanked}},
title = {{Clover Health Investments — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/clover-health-investments}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001801170-26-000057 · February 27, 2026
{{cite web |title=Clover Health Investments — Key figures — 10-K (0001801170-26-000057) |url=https://www.sec.gov/Archives/edgar/data/1801170/000180117026000057/clov-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.